Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Eli Lilly and Company (LLY)

-NYSE
86.14 Up 1.29(1.52%) Jul 2, 4:04PM EDT
Add to Portfolio
Prev Close:84.85
Open:85.21
Bid:86.20 x 200
Ask:86.50 x 500
1y Target Est:85.61
Beta:0.4
Next Earnings Date:23-Jul-15LLY Earnings announcement
Day's Range:84.69 - 86.24
52wk Range:60.14 - 87.24
Volume:5,128,085
Avg Vol (3m):5,062,830
Market Cap:91.22B
P/E (ttm):42.02
EPS (ttm):2.05
Div & Yield:2.00 (2.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LLYUp 1.52%91.22B
GSKUp 0.28%102.06B
PFEDown 0.95%205.48B
SNYDown 0.58%129.36B

Key Statistics

Forward P/E (1 yr):24.40
P/S (ttm):4.61
Ex-Dividend Date:12-Aug-15

Analysts

Annual EPS Est (Dec-15) :3.16
Quarterly EPS Est (Jun-15) :0.73
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):5.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback